BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kao TJ, Wu CC, Phan NN, Liu YH, Ta HDK, Anuraga G, Wu YF, Lee KH, Chuang JY, Wang CY. Prognoses and genomic analyses of proteasome 26S subunit, ATPase (PSMC) family genes in clinical breast cancer. Aging (Albany NY) 2021;13:17970. [PMID: 34329194 DOI: 10.18632/aging.203345] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
Number Citing Articles
1 Zhao Y, Bai Y, Shen M, Li Y. Therapeutic strategies for gastric cancer targeting immune cells: Future directions. Front Immunol 2022;13:992762. [DOI: 10.3389/fimmu.2022.992762] [Reference Citation Analysis]
2 Luo Q, Li J, Su X, Tan Q, Zhou F, Xie S. COL11A1 serves as a biomarker for poor prognosis and correlates with immune infiltration in breast cancer. Front Genet 2022;13:935860. [DOI: 10.3389/fgene.2022.935860] [Reference Citation Analysis]
3 Xuan DTM, Yeh I, Wu C, Su C, Liu H, Chiao C, Ku S, Jiang J, Sun Z, Ta HDK, Anuraga G, Wang C, Yen M, Xu B. Comparison of Transcriptomic Signatures between Monkeypox-Infected Monkey and Human Cell Lines. Journal of Immunology Research 2022;2022:1-17. [DOI: 10.1155/2022/3883822] [Reference Citation Analysis]
4 Ullah MA, Islam NN, Moin AT, Park SH, Kim B. Evaluating the Prognostic and Therapeutic Potentials of the Proteasome 26S Subunit, ATPase (PSMC) Family of Genes in Lung Adenocarcinoma: A Database Mining Approach. Front Genet 2022;13:935286. [DOI: 10.3389/fgene.2022.935286] [Reference Citation Analysis]
5 Li Q, Zhang P, Hu H, Huang H, Pan D, Mao G, Hu B. The DDR-related gene signature with cell cycle checkpoint function predicts prognosis, immune activity, and chemoradiotherapy response in lung adenocarcinoma. Respir Res 2022;23:190. [PMID: 35840978 DOI: 10.1186/s12931-022-02110-w] [Reference Citation Analysis]
6 Wang N, Gu Y, Li L, Chi J, Liu X, Xiong Y, Zhong C. Development and Validation of a Prognostic Classifier Based on Lipid Metabolism-Related Genes for Breast Cancer. J Inflamm Res 2022;15:3477-99. [PMID: 35726216 DOI: 10.2147/JIR.S357144] [Reference Citation Analysis]
7 Fan Y, Zhang J, Shi J, Chen L, Long J, Zhang S, Liu S, Schmalz G. Genetic Cross-Talk between Oral Squamous Cell Carcinoma and Type 2 Diabetes: The Potential Role of Immunity. Disease Markers 2022;2022:1-24. [DOI: 10.1155/2022/6389906] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhou Y, Guo S, Li Y, Chen F, Wu Y, Xiao Y, An J. METTL3 Is Associated With the Malignancy of Esophageal Squamous Cell Carcinoma and Serves as a Potential Immunotherapy Biomarker. Front Oncol 2022;12:824190. [PMID: 35574315 DOI: 10.3389/fonc.2022.824190] [Reference Citation Analysis]
9 Tian T, Fu J, Li D, Liu Y, Sun H, Wang X, Zhang X, Zhang D, Zheng T, Zhao Y, Pang D. Methylation of Immune-Related Genes in Peripheral Blood Leukocytes and Breast Cancer. Front Oncol 2022;12:817565. [PMID: 35223499 DOI: 10.3389/fonc.2022.817565] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Xu J, Li J. . MBE 2022;19:13483-525. [DOI: 10.3934/mbe.2022630] [Reference Citation Analysis]
11 Wu PS, Wang CY, Chen PS, Hung JH, Yen JH, Wu MJ. 8-Hydroxydaidzein Downregulates JAK/STAT, MMP, Oxidative Phosphorylation, and PI3K/AKT Pathways in K562 Cells. Biomedicines 2021;9:1907. [PMID: 34944720 DOI: 10.3390/biomedicines9121907] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
12 Ta HDK, Minh Xuan DT, Tang WC, Anuraga G, Ni YC, Pan SR, Wu YF, Fitriani F, Putri Hermanto EM, Athoillah M, Andriani V, Ajiningrum PS, Wang CY, Lee KH. Novel Insights into the Prognosis and Immunological Value of the SLC35A (Solute Carrier 35A) Family Genes in Human Breast Cancer. Biomedicines 2021;9:1804. [PMID: 34944621 DOI: 10.3390/biomedicines9121804] [Reference Citation Analysis]
13 Xuan DTM, Wu CC, Kao TJ, Ta HDK, Anuraga G, Andriani V, Athoillah M, Chiao CC, Wu YF, Lee KH, Wang CY, Chuang JY. Prognostic and immune infiltration signatures of proteasome 26S subunit, non-ATPase (PSMD) family genes in breast cancer patients. Aging (Albany NY) 2021;13:24882-913. [PMID: 34839279 DOI: 10.18632/aging.203722] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
14 Chiao CC, Liu YH, Phan NN, An Ton NT, Ta HDK, Anuraga G, Minh Xuan DT, Fitriani F, Putri Hermanto EM, Athoillah M, Andriani V, Ajiningrum PS, Wu YF, Lee KH, Chuang JY, Wang CY, Kao TJ. Prognostic and Genomic Analysis of Proteasome 20S Subunit Alpha (PSMA) Family Members in Breast Cancer. Diagnostics (Basel) 2021;11:2220. [PMID: 34943457 DOI: 10.3390/diagnostics11122220] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Chou CW, Hsieh YH, Ku SC, Shen WJ, Anuraga G, Khoa Ta HD, Lee KH, Lee YC, Lin CH, Wang CY, Wang WJ. Potential Prognostic Biomarkers of OSBPL Family Genes in Patients with Pancreatic Ductal Adenocarcinoma. Biomedicines 2021;9:1601. [PMID: 34829830 DOI: 10.3390/biomedicines9111601] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
16 Prayugo FB, Kao TJ, Anuraga G, Ta HDK, Chuang JY, Lin LC, Wu YF, Wang CY, Lee KH. Expression Profiles and Prognostic Value of FABPs in Colorectal Adenocarcinomas. Biomedicines 2021;9:1460. [PMID: 34680577 DOI: 10.3390/biomedicines9101460] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
17 Sui S, Xu S, Pang D. Emerging role of ferroptosis in breast cancer: New dawn for overcoming tumor progression. Pharmacol Ther 2021;:107992. [PMID: 34606782 DOI: 10.1016/j.pharmthera.2021.107992] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
18 Ta HDK, Wang WJ, Phan NN, An Ton NT, Anuraga G, Ku SC, Wu YF, Wang CY, Lee KH. Potential Therapeutic and Prognostic Values of LSM Family Genes in Breast Cancer. Cancers (Basel) 2021;13:4902. [PMID: 34638387 DOI: 10.3390/cancers13194902] [Cited by in Crossref: 3] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]